3
INTRODUCTION
Gout resultsfrom the precipitation of urate crystals in
the tissues and the subsequent inflammatory
response.
Acute gout causes a very painful distal mono arthritis,
it can also cause joint destruction, subcutaneous
deposits (tophi) and renal calculi.
4.
Gout isusually associated with
hyperuricemia.
Treatment is aimed at relieving the acute
gouty attacks and preventing recurrent gouty
episodes and urate lithiasis.
4
11
Drugs For ChronicGout
1. Drugs which increase the excretion of uric acid
(Uricosuric Agents)
Probenecid
Sulfinpyrazone
2. Drugs which decrease the synthesis of uric acid
(Xanthine oxidase inhibitors))
Allopurinol
12.
12
COLCHICINE
Source: -
Alkaloid derivedfrom Colchicum Autumnale (Plant).
Pharmacokinetics: -
Oral absorption is good
PPLs 2 hrs
Metabolism in liver.
80% Metabolites excreted in feces through bile.
20% in urine.
13.
13
Colchicine relieves painin 12-24 hours
Binds to intracellular protein tubulin
Prevents its polymerization into microtubules
Inhibition of mitosis in fast growing cells
Reduction in inflammatory cells
Pharmacodynamics
14.
Apart fromthis colchicine inhibits neutrophil
motility and activity it also inhibits the deposition
of urate crystals by changing the Ph.
14
15.
15
Therapeutic Uses
Acutegouty arthritis.
Prophylaxis of recurrent episodes of gouty
arthritis.
Prevention of attacks of acute Mediterranean
fever.
(Familial Mediterranean fever is an inherited condition characterized by recurrent
episodes of painful inflammation in the abdomen, chest, or joints.
These episodes are often accompanied by fever and sometimes a rash or
headache).
16.
16
Adverse Effect
Diarrhea(often) and nausea, vomiting
and abdominal pain on oral administration.
Rarely it can cause Hepatic necrosis, Acute renal failure, DIC
and seizures
Hair loss
BM depression very rarely occur
Peripheral Neuritis
17.
Overdose is characterizedby the following:
•Burning throat pain.
•Hemorrhagic gastroenteritis.
•Extensive vascular damage.
17
18.
18
Rx & Dosage(Prophylactic & for acute
attack)
For Prophylaxis:
0.6 mg once- thrice a day.
For Termination of an acute attack:
0.6 mg- 1.2 mg initially followed by 0.6 mg every
2 hours until pain is relieved or nausea and
diarrhea appears.
19.
19
ALLOPURINOL (Zyloric)
Chemistry –isomer of hypoxanthine
Pharmacokinetics
80 % absorbed on oral administration
Metabolized by xanthine oxidase
Metabolite Alloxanthine retains the capacity to inhibit xanthine
oxidase (long duration of action – OD dose)
Plasma Half Life = 2 – 3 hrs
Plasma Half Life of Metabolite = 18 - 30 hrs
21
Therapeutic Uses
Hyperuricemia.
Intercritical period of gout (continued for life).
Chronic tophaceous gout and gouty nephropathy.
Use in patients allergic or intolerant to Probenecid &
Sulfinpyrazone.
Antiprotozoal agent.
22.
What are Tophi?
A tophus is a feature of longstanding gout and is the
result of the body's inflammatory response to deposited
MSU monosodium urate monohydrate crystals.
Tophaceous deposits appear hyperechoic, with an
anechoic rim, and can have a nodular or infiltrative
appearance.
22
26
Precautions: Acute attackof gout.
slow in dosage.
Interactions
1. metabolism of mercaptopurine (
dose) & Azothiprine
2. Hypersensitivity if given along with
ampicillin.
3. metabolism of Probenecid and
oral anticoagulants
27.
27
Dosage of Allopurinol
Initial dose 100mg once daily may be titrated
upto 300 mg/d depending on the response.
In severe cases 400-600 mg can be given.
28.
28
Febuxostat
The firstnonpurine inhibitor of xanthine oxidase
80 % absorbed after oral administration.
Reaches peak plasma concentration in 1 hr.
Dose of 80 mg and 120 mg more effective than
300 mg Allopurinol.
Adverse effect diarrhea, nausea and headache.
29.
29
Probenecid & Sulfinpyrazone
Uricosuricdrugs:
Employed to the body pool of urate in pts with
tophaceous gout or in those with increasingly
frequency gouty attacks, should be avoided in pts
excreting large amounts of uric acid, so as not to
precipitate the formation of uric acid calculi in urinary
tracts.
30.
30
Probenecid & Sulfinpyrazone
Pharmacokinetics:
Probenecidis completely reabsorbed by the renal tubules
and is metabolized very slowly.
Sulfinpyrazone or its active hydroxylated derivative in
rapidly excreted by the kidneys so effect after oral
administration is almost as long as that of probenecid.
31.
31
MOA of Probenecid& Sulfinpyrazone
At therapeutic doses they block proximal tubular
reabsorption of uric acid increased excretion of uric
acid in the urine decrease urate pool relief of
arthritis and remineralization of bone.
However on persistent increase in uric acid excretion renal
stone formation is augmented within urinary tracts.
32.
32
Therapeutic Uses
Chronic gout
Probenecidinhibits tubular secretion of penicillin and may be used
to prolong in levels of penicillin.
Adverse Effects
Renal stone formation ( maintain a large urinary volume)
GIT irritation (Sulfinpyrazone)
Allergic dermatitis (Probenecid)
Aplastic anemia (both cause this rarely)
Nephrotic syndrome (Probenecid)
33.
Pegloticase
Recombinant formof the enzyme urate oxidase or
uricase.
Acts by converting uric acid allantoin, water soluble
non-toxic metabolite excretion by kidneys.
Administration : IV route.
Adverse effects are infusion related Anaphylaxis.
Patients should be pre-medicated with antihistamines &
corticosteroids.
33